Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1801140
Max Phase: Preclinical
Molecular Formula: C116H177N35O39S6
Molecular Weight: 2878.30
Molecule Type: Protein
Associated Items:
ID: ALA1801140
Max Phase: Preclinical
Molecular Formula: C116H177N35O39S6
Molecular Weight: 2878.30
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C1=O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N4)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC3=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c3ccccc13)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N2
Standard InChI: InChI=1S/C116H177N35O39S6/c1-49(2)31-64-113(188)149-28-17-23-75(149)105(180)144-86(51(5)6)108(183)138-68-43-191-192-44-69-99(174)135-67(42-153)98(173)137-70-45-193-195-47-72(141-112(187)90(55(11)156)146-95(170)61(25-26-84(165)166)128-80(161)38-125-93(68)168)102(177)143-85(50(3)4)107(182)127-36-79(160)123-37-83(164)142-88(53(9)154)110(185)140-71(100(175)133-63(34-78(118)159)96(171)148-91(56(12)157)115(190)151-30-16-22-74(151)104(179)126-40-82(163)130-69)46-194-196-48-73(103(178)147-89(54(10)155)111(186)131-60(21-15-27-121-116(119)120)94(169)132-62(33-77(117)158)92(167)124-39-81(162)129-64)139-109(184)87(52(7)8)145-106(181)76-24-18-29-150(76)114(189)65(134-97(172)66(41-152)136-101(70)176)32-57-35-122-59-20-14-13-19-58(57)59/h13-14,19-20,35,49-56,60-76,85-91,122,152-157H,15-18,21-34,36-48H2,1-12H3,(H2,117,158)(H2,118,159)(H,123,160)(H,124,167)(H,125,168)(H,126,179)(H,127,182)(H,128,161)(H,129,162)(H,130,163)(H,131,186)(H,132,169)(H,133,175)(H,134,172)(H,135,174)(H,136,176)(H,137,173)(H,138,183)(H,139,184)(H,140,185)(H,141,187)(H,142,164)(H,143,177)(H,144,180)(H,145,181)(H,146,170)(H,147,178)(H,148,171)(H,165,166)(H4,119,120,121)/t53-,54-,55-,56-,60+,61+,62+,63+,64+,65+,66+,67+,68+,69+,70+,71+,72+,73+,74+,75+,76+,85+,86+,87+,88+,89+,90+,91+/m1/s1
Standard InChI Key: JJTSSFQTAAWSTF-DXBOVLASSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 2878.30 | Molecular Weight (Monoisotopic): 2876.1267 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Ireland DC, Clark RJ, Daly NL, Craik DJ.. (2010) Isolation, sequencing, and structure-activity relationships of cyclotides., 73 (9): [PMID:20718473] [10.1021/np1000413] |
2. Dang TT, Chan LY, Huang YH, Nguyen LTT, Kaas Q, Huynh T, Craik DJ.. (2020) Exploring the Sequence Diversity of Cyclotides from Vietnamese Viola Species., 83 (6): [PMID:32437150] [10.1021/acs.jnatprod.9b01218] |
Source(1):